Long-lasting substance-P-mediated modulation of NMDA-induced rhythmic activity in the lamprey locomotor network involves separate RNA- and protein-synthesis-dependent stages

Eur J Neurosci. 1999 May;11(5):1515-22. doi: 10.1046/j.1460-9568.1999.00565.x.

Abstract

Bath application of the tachykinin neuropeptide substance P (1 microm) for 10 min causes long-lasting (> 24 h) modulation of the frequency and regularity of NMDA-evoked locomotor bursts in the lamprey. The change in burst frequency has an induction phase (< 2 h), which depends on the potentiation of NMDA responses and an increase in intracellular calcium levels, and a maintenance phase (> 2 h), that is blocked by translational protein synthesis inhibitors. Here, the maintenance phase has been examined further. Unlike translation inhibitors, the transcription inhibitors actinomycin D and 5,6-dichlorobenzimidazole riboside (DRB) failed to reverse the change in burst frequency 2-3 h after substance P application, suggesting that the protein synthesized at this time does not require de novo RNA synthesis. Transcription inhibitors, however, reversed the change in burst frequency 15-24 h after substance P application, as did brefeldin A, which disrupts the Golgi complex and thus interferes with the post-translational transport of proteins. The change in burst regularity was unaffected by transcription or translation inhibitors, but was partially reversed by protein kinase A inhibitors applied 2.5-8 h after substance P. The glycoprotein synthesis inhibitor 2-deoxygalactose did not affect the changes in burst frequency or burst regularity. These results suggest that there are two phases to the maintenance of the change in burst frequency: an intermediate protein-, but not RNA-, synthesis-dependent phase, and a final RNA-synthesis-dependent phase. The change in burst regularity is protein-synthesis-independent, but may depend on activation of protein kinase A for at least 8 h after substance P application.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dactinomycin / pharmacology
  • Dichlororibofuranosylbenzimidazole / pharmacology
  • Female
  • Gene Expression / drug effects
  • Glycoproteins / biosynthesis
  • Glycoproteins / genetics
  • Glycoproteins / metabolism
  • Golgi Apparatus / physiology
  • Lampreys
  • Male
  • Motor Neurons / chemistry*
  • Motor Neurons / enzymology
  • Neurotransmitter Agents / biosynthesis
  • Neurotransmitter Agents / genetics
  • Neurotransmitter Agents / metabolism
  • Nucleic Acid Synthesis Inhibitors / pharmacology
  • Periodicity*
  • Protein Kinase C / metabolism
  • Protein Synthesis Inhibitors / pharmacology
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / metabolism
  • Receptors, N-Methyl-D-Aspartate / physiology*
  • Substance P / pharmacology*
  • Swimming / physiology*

Substances

  • Glycoproteins
  • Neurotransmitter Agents
  • Nucleic Acid Synthesis Inhibitors
  • Protein Synthesis Inhibitors
  • RNA, Messenger
  • Receptors, N-Methyl-D-Aspartate
  • Dactinomycin
  • Substance P
  • Dichlororibofuranosylbenzimidazole
  • Protein Kinase C